THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 2 filers reported holding THERAPEUTICSMD INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $76,789 | +6.7% | 202,077 | 0.0% | 0.00% | – |
Q4 2021 | $72,000 | -61.7% | 202,077 | -20.4% | 0.00% | – |
Q3 2021 | $188,000 | -27.1% | 253,880 | +16.9% | 0.00% | – |
Q2 2021 | $258,000 | -3.0% | 217,207 | +9.5% | 0.00% | – |
Q1 2021 | $266,000 | +31.0% | 198,380 | +18.4% | 0.00% | – |
Q4 2020 | $203,000 | -13.2% | 167,516 | +13.3% | 0.00% | – |
Q3 2020 | $234,000 | +34.5% | 147,864 | 0.0% | 0.00% | – |
Q2 2020 | $174,000 | +13.0% | 147,864 | +1.7% | 0.00% | – |
Q1 2020 | $154,000 | -47.6% | 145,330 | +19.6% | 0.00% | – |
Q4 2019 | $294,000 | -37.6% | 121,465 | -2.6% | 0.00% | -100.0% |
Q3 2019 | $471,000 | +41.9% | 124,658 | -2.3% | 0.00% | – |
Q2 2019 | $332,000 | -44.6% | 127,585 | +3.8% | 0.00% | -100.0% |
Q1 2019 | $599,000 | +23.3% | 122,913 | -3.7% | 0.00% | 0.0% |
Q4 2018 | $486,000 | -39.2% | 127,633 | +4.7% | 0.00% | 0.0% |
Q3 2018 | $800,000 | +0.9% | 121,926 | -4.1% | 0.00% | 0.0% |
Q2 2018 | $793,000 | +29.8% | 127,115 | +1.2% | 0.00% | 0.0% |
Q1 2018 | $611,000 | -21.1% | 125,560 | -2.0% | 0.00% | 0.0% |
Q4 2017 | $774,000 | +20.2% | 128,099 | +5.1% | 0.00% | 0.0% |
Q3 2017 | $644,000 | -1.1% | 121,883 | -1.4% | 0.00% | 0.0% |
Q2 2017 | $651,000 | -24.4% | 123,580 | +3.4% | 0.00% | 0.0% |
Q1 2017 | $861,000 | +42.3% | 119,522 | +14.0% | 0.00% | 0.0% |
Q4 2016 | $605,000 | -14.8% | 104,855 | +0.6% | 0.00% | 0.0% |
Q3 2016 | $710,000 | -19.1% | 104,223 | +0.9% | 0.00% | 0.0% |
Q2 2016 | $878,000 | +53.0% | 103,248 | +15.7% | 0.00% | – |
Q1 2016 | $574,000 | -35.1% | 89,205 | +4.5% | 0.00% | -100.0% |
Q4 2015 | $885,000 | +78.8% | 85,340 | +1.0% | 0.00% | 0.0% |
Q3 2015 | $495,000 | -23.6% | 84,459 | +2.4% | 0.00% | 0.0% |
Q2 2015 | $648,000 | +38.8% | 82,451 | +6.7% | 0.00% | 0.0% |
Q1 2015 | $467,000 | +49.2% | 77,241 | +9.9% | 0.00% | – |
Q4 2014 | $313,000 | -6.6% | 70,305 | -2.4% | 0.00% | – |
Q3 2014 | $335,000 | +14.3% | 72,048 | +8.8% | 0.00% | – |
Q2 2014 | $293,000 | -30.4% | 66,221 | -0.7% | 0.00% | -100.0% |
Q1 2014 | $421,000 | +26.0% | 66,717 | +4.2% | 0.00% | 0.0% |
Q4 2013 | $334,000 | +93.1% | 64,041 | +8.7% | 0.00% | – |
Q3 2013 | $173,000 | -8.9% | 58,895 | -6.5% | 0.00% | – |
Q2 2013 | $190,000 | – | 62,957 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |